RIGON, LAURA
RIGON, LAURA
Dipartimento di Medicina - DIMED
A GENOMIC DELETION SPANNING PART OF LGI1 ASSOCIATED WITH AUTOSOMAL DOMINANT LATERAL TEMPORAL EPILEPSY
2011 Fanciulli, M; Santulli, L; Errichiello, L; de Falco, A; Rigon, Laura; Striano, P; Michelucci, R; Striano, S; de Falco, F; Nobile, C.
ADAM23, a Gene Related to LGI1, Is Not Linked to Autosomal Dominant Lateral Temporal Epilepsy.
2011 Rigon, Laura; Vettori, Andrea; Busolin, Giorgia; Egeo, G; Pulitano, P; Santulli, L; Pasini, E; Striano, P; la Neve, A; Vianello Dri, V; Boniver, C; Gambardella, A; Banfi, P; Binelli, S; Di Bonaventura, C; Striano, S; de Falco, F; Giallonardo, At; Mecarelli, O; Michelucci, R; Nobile, C.
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach
2014 Rigon, Laura; Salvalaio, Marika; Tosi, Giovanni; Belletti, Daniela; D'Avanzo, Francesca; Ruozi, Barbara; Vandelli, Maria Angela; Forni, Flavio; Scarpa, Maurizio; Tomanin, Rosella
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model
2017 Salvalaio, Marika; D’Avanzo, Francesca; Rigon, Laura; Zanetti, Alessandra; D’Angelo, Michela; Valle, Giorgio; Scarpa, Maurizio; Tomanin, Rosella
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment
2013 Mazzoccoli, G; Tomanin, Rosella; Mazza, T; D'Avanzo, Francesca; Salvalaio, Marika; Rigon, Laura; Zanetti, Alessandra; Pazienza, V; Francavilla, M; Giuliani, F; Vinciguerra, M; Scarpa, Maurizio
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis
2018 Maccari, F.; Galeotti, F.; Mantovani, V.; Zampini, L.; Padella, L.; Rigon, L.; Concolino, D.; Fiumara, A.; Pascale, E.; Pittala, A.; Galeazzi, T.; Monachesi, C.; Marchesiello, R. L.; Coppa, G.; Gabrielli, O.; Volpi, N.
Corrigendum: FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII) [Human Molecular Genetics, 27, 13, (2018) (2262-2275)] DOI: 10.1093/hmg/ddy131
2018 Bellesso, S.; Salvalaio, M.; Lualdi, S.; Tognon, E.; Costa, R.; Braghetta, P.; Giraudo, C.; Stramare, R.; Rigon, L.; Filocamo, M.; Tomanin, R.; Moro, E.
Development of an Ex Vivo Gene Therapy for Frontotemporal Dementia (FTD)
2022 Ciervo, Y; Rigon, L; Spadini, S; Accardo, M; Milazzo, R; Biffi, A
Drosophila d-idua reduction mimics mucopolysaccharidosis type i disease-related phenotypes
2022 De Filippis, C.; Napoli, B.; Rigon, L.; Guarato, G.; Bauer, R.; Tomanin, R.; Orso, G.
Early diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approach
2017 Gabrielli, O.; Zampini, L.; Monachesi, C.; Marchesiello, R. L.; Padella, L.; Santoro, L.; Volpi, N.; Concolino, D.; Fiumara, A.; Rigon, L.; Mazzoli, M.; Carnielli, V. P.; Giovagnoni, A.; Catassi, C.; Galeazzi, T.; Coppa, G. V.
Exploiting the potential of drosophila models in lysosomal storage disorders: Pathological mechanisms and drug discovery
2021 Rigon, L.; De Filippis, C.; Napoli, B.; Tomanin, R.; Orso, G.
Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation
2011 Striano, P; Busolin, Giorgia; Santulli, L; Leonardi, E; Coppola, A; Vitiello, Libero; Rigon, Laura; Michelucci, R; Tosatto, Silvio; Striano, S; Nobile, C.
FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII).
2018 Bellesso, Stefania; Salvalaio, Marika; Lualdi, Susanaa; Tognon, Elisa; Costa, Roberto; Braghetta, Paola; Giraudo, Chiara; Stramare, Roberto; Rigon, Laura; Filocamo, Mirella; Tomanin, Rosella; Moro, Enrico
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy
2022 Maccari, F.; Rigon, L.; Mantovani, V.; Galeotti, F.; Salvalaio, M.; D'Avanzo, F.; Zanetti, A.; Capitani, F.; Gabrielli, O.; Tomanin, R.; Volpi, N.
Hematopoietic Stem and Progenitor Cell Gene Therapy Uniquely Benefits Multiple Sclerosis in the Animal Model
2022 Spadini, S; Milazzo, R; Rigon, L; Accardo, M; Santinon, G; Ciervo, Y; Costa, A; Peviani, M; Ben Nasr, M; Rizzardi, Gp; Fiorina, P; Biffi, A
LGI1 microdeletion in autosomal dominant lateral temporal epilepsy.
2012 Fanciulli, M; Santulli, L; Errichiello, L; Barozzi, C; Tomasi, L; Rigon, Laura; Cubeddu, T; de Falco, A; Rampazzo, Alessandra; Michelucci, R; Uzzau, S; Striano, S; de Falco, Fa; Striano, P; Nobile, C.
Modeling Mucopolysaccharidosis Type II in the Fruit Fly by Using the RNA Interference Approach
2020 Rigon, Laura; Kucharowski, Nicole; Eckardt, Franka; Bauer, Reinhard
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study
2019 Zanetti, A.; D'Avanzo, F.; Rigon, L.; Rampazzo, A.; Concolino, D.; Barone, R.; Volpi, N.; Santoro, L.; Lualdi, S.; Bertola, F.; Scarpa, M.; Tomanin, R.
Mucopolysaccharidosis type II: One hundred years of research, diagnosis, and treatment
2020 Dʹavanzo, F.; Rigon, L.; Zanetti, A.; Tomanin, R.
Nanotechnologies for CNS drug delivery: therapy for the neurological compartment in the Mucopolisaccharidoses
2015 Rigon, Laura